{
    "Trade/Device Name(s)": [
        "IDEAL LIFE Gluco-Manager\u2122M Blood Glucose Monitoring System",
        "IDEAL LIFE Blood Glucose Test Strips, Model AGS-1112",
        "IDEAL LIFE Control Solution, Model GCS-0104",
        "IDEAL LIFE Pod\u2122M",
        "IDEAL LIFE Gateway Application\u2122M"
    ],
    "Submitter Information": "Ideal Life Inc.",
    "510(k) Number": "K132180",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110017"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JQP",
        "JJX"
    ],
    "Summary Letter Date": "June 16, 2014",
    "Summary Letter Received Date": "June 16, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "IDEAL LIFE Gluco-Manager\u2122M",
        "IDEAL LIFE Gateway Application\u2122M",
        "IDEAL LIFE Pod\u2122M"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor",
        "Amperometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Control Solution",
        "Mobile Application",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for IDEAL LIFE Gluco-Manager\u2122M blood glucose monitoring system and accessories for self-testing of blood glucose in people with diabetes.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from fingertip or alternative sites by people with diabetes at home for self-testing as an aid to monitor diabetes control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}